Eupraxia Pharmaceuticals Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BEUTEL, GOODMAN & CO LTD. | 02/13/2026 | 3.71 M | $27.93 M | -8.61% | 11.08% |
| BALYASNY ASSET MANAGEMENT L.P. | 02/17/2026 | 1.35 M | $10.19 M | 0.00% | 4.03% |
| VIVO CAPITAL, LLC | 02/13/2026 | 1.35 M | $10.19 M | 0.00% | 4.03% |
| SCOTIA CAPITAL INC. | 02/12/2026 | 1.29 M | $9.60 M | 0.65% | 3.84% |
| GREAT POINT PARTNERS LLC | 02/17/2026 | 1.20 M | $9.06 M | 0.00% | 3.58% |
| POINT72 ASSET MANAGEMENT, L.P. | 02/17/2026 | 712.10 K | $5.38 M | 100.00% | 2.13% |
| IKARIAN CAPITAL, LLC | 02/18/2026 | 610.00 K | $4.61 M | 100.00% | 1.82% |
| 02/17/2026 | 500.00 K | $3.78 M | 100.00% | 1.49% | |
| ALLY BRIDGE GROUP (NY) LLC | 02/17/2026 | 397.90 K | $3.00 M | -56.51% | 1.19% |
| VELAN CAPITAL INVESTMENT MANAGEMENT LP | 02/13/2026 | 352.00 K | $2.66 M | 0.00% | 1.05% |
| AFFINITY ASSET ADVISORS, LLC | 02/13/2026 | 300.00 K | $2.27 M | 0.00% | 0.90% |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 02/13/2026 | 278.06 K | $2.09 M | 100.00% | 0.83% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 253.32 K | $1.91 M | 455.81% | 0.76% |
| UBS GROUP AG | 01/29/2026 | 220.02 K | $1.66 M | 129.78% | 0.66% |
| ROYAL BANK OF CANADA | 02/17/2026 | 196.28 K | $1.48 M | -54.23% | 0.59% |
| SUMMITTX CAPITAL, L.P. | 02/17/2026 | 175.95 K | $1.33 M | 100.00% | 0.53% |
| MARSHALL WACE, LLP | 02/13/2026 | 158.13 K | $1.19 M | 100.00% | 0.47% |
| BOOTHBAY FUND MANAGEMENT, LLC | 02/17/2026 | 156.33 K | $1.18 M | 100.00% | 0.47% |
| ACADIAN ASSET MANAGEMENT LLC | 02/10/2026 | 155.77 K | $1.17 M | 627.88% | 0.47% |
| INGALLS & SNYDER LLC | 02/13/2026 | 77.40 K | $584.00 K | 30.96% | 0.23% |
| GOLDMAN SACHS GROUP INC | 03/25/2026 | 58.06 K | $438.34 K | 44.78% | 0.17% |
| CIBC WORLD MARKET INC. | 02/10/2026 | 58.05 K | $436.54 K | 287.00% | 0.17% |
| RAYMOND JAMES FINANCIAL INC | 02/18/2026 | 52.97 K | $399.94 K | 58.73% | 0.16% |
| QUADRATURE CAPITAL LTD | 02/17/2026 | 43.19 K | $325.63 K | 100.00% | 0.13% |
| BANK OF MONTREAL /CAN/ | 02/12/2026 | 37.25 K | $280.08 K | 0.00% | 0.11% |
| 1832 ASSET MANAGEMENT L.P. | 02/13/2026 | 32.14 K | $242.64 K | 100.00% | 0.10% |
| JANE STREET GROUP, LLC | 02/12/2026 | 29.62 K | $222.78 K | 100.00% | 0.09% |
| XTX TOPCO LTD | 02/17/2026 | 16.18 K | $122.16 K | 100.00% | 0.05% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 13.90 K | $104.94 K | 100.00% | 0.04% |
| TCI WEALTH ADVISORS, INC. | 02/02/2026 | 11.00 K | $83.05 K | 0.00% | 0.03% |
| APTUS CAPITAL ADVISORS, LLC | 02/13/2026 | 10.00 K | $75.50 K | 100.00% | 0.03% |
| GUARDIAN WEALTH ADVISORS, LLC / NC | 02/17/2026 | 10.00 K | $75.50 K | 100.00% | 0.03% |
| TD WATERHOUSE CANADA INC. | 01/27/2026 | 9.60 K | $71.69 K | 0.00% | 0.03% |
| FEDERATION DES CAISSES DESJARDINS DU QUEBEC | 02/12/2026 | 9.09 K | $67.89 K | 0.00% | 0.03% |
| NATIONAL BANK OF CANADA /FI/ | 02/17/2026 | 586 | $4.44 K | -33.56% | 0.00% |
| JPMORGAN CHASE & CO | 02/11/2026 | 0 | $0 | -100.00% | 0.00% |
| ALYESKA INVESTMENT GROUP, L.P. | 02/13/2026 | 0 | $0 | -100.00% | 0.00% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 02/17/2026 | 0 | $0 | -100.00% | 0.00% |
| INTEGRATED WEALTH CONCEPTS LLC | 02/13/2026 | 0 | $0 | -100.00% | 0.00% |
| LOGOS GLOBAL MANAGEMENT LP | 02/17/2026 | 0 | $0 | -100.00% | 0.00% |
| GUARDIAN PARTNERS INC. | 02/17/2026 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Eupraxia Pharmaceuticals Inc institutional Ownership - FAQ's
During the previous two years, 46 institutional investors and hedge funds held shares of Eupraxia Pharmaceuticals Inc. The most heavily invested institutionals were:
UBS Group AG: 762,635
Aisling Capital Management LP: 325,000
TD Waterhouse Canada Inc.: 81,725
Persistent Asset Partners Ltd: 37,926
JANE STREET GROUP, LLC: 35,210
TCI Wealth Advisors, Inc.: 11,000
41.31% of Eupraxia Pharmaceuticals Inc stock is owned by institutional investors.
Institutional investors have bought a total of 14.34 M shares in the last 24 months. This purchase volume represents approximately $112.14 M in transactions.